Search filters

List of works by Masahiro Sugihara

Analysis of the serum bile Acid composition for differential diagnosis in patients with liver disease

scientific article

Anti-high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy

scientific article published on 3 September 2015

Chemotherapy for non-small cell lung cancer: split-dose administration of Cisplatin over four consecutive days and Vinorelbine ditartrate

scientific article published in February 2009

Estimating antihypertensive effects of combination therapy in an observational study using marginal structural models

scientific article published in October 2009

Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum

scientific article

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients

article

Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis

scientific article published on 29 August 2015

Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

scientific article

Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan

scientific article

Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score

scientific article published in January 2010

The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study

scientific article published on 27 January 2014

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

article published in 2019

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study

scientific article published on 29 April 2019

Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts